Improving heart failure care through a digital self-care program in Uganda
ImpleMEntation of a Digital-first care deLiverY model for heart failure in Uganda (MEDLY Uganda)
This study is testing a new digital program called Medly Uganda to help people with heart failure in Uganda take better care of themselves and improve their health, making it easier for them to manage their condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-11178892 on NIH RePORTER |
What this research studies
This research focuses on enhancing heart failure management in Uganda by implementing a digital-first care delivery model called Medly Uganda. The program aims to empower patients with tools and knowledge for self-care, addressing significant gaps in heart failure treatment in low- and middle-income countries. By utilizing a mixed-methods approach, the study will evaluate both the implementation of this digital strategy and its clinical effectiveness in improving patient outcomes. The research will take place in six outpatient departments of regional referral hospitals in Uganda.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with heart failure who are receiving care at participating outpatient departments in Uganda.
Not a fit: Patients with heart failure who are not located in Uganda or those who do not have access to the digital tools required for participation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the quality of life and health outcomes for patients with heart failure in Uganda.
How similar studies have performed: Previous research has shown that digital self-care interventions can improve health outcomes in similar populations, suggesting a promising avenue for this approach.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Schwartz, Jeremy Ian — Yale University
- Study coordinator: Schwartz, Jeremy Ian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.